These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20556836)

  • 1. High-sensitivity C-reactive protein in paediatric inflammatory bowel disease.
    Sidoroff M; Karikoski R; Raivio T; Savilahti E; Kolho KL
    World J Gastroenterol; 2010 Jun; 16(23):2901-6. PubMed ID: 20556836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.
    Solem CA; Loftus EV; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
    Inflamm Bowel Dis; 2005 Aug; 11(8):707-12. PubMed ID: 16043984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of Bayer wide-range C-reactive protein (wr-CRP) and the Dade-Behring high sensitivity C-reactive protein (hs-CRP) in patients with inflammatory bowel disease.
    Maharshak N; Arbel Y; Gal-Oz A; Rogowski O; Shapira I; Berliner S; Vered Y; Canaani J; Dotan I
    J Dig Dis; 2008 Aug; 9(3):140-3. PubMed ID: 18956591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inflammatory bowel disease in children--an analysis of the clinical symptoms and selected biochemical parameters].
    Landowski P; Liberek A; Szlagatys-Sidorkiewicz A; Radys W; Brodzicki J; Szarszewski A; Marek A; Łuczak G; Kamińska B
    Med Wieku Rozwoj; 2007; 11(4):401-7. PubMed ID: 18605192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
    Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K
    Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum galectins as potential biomarkers of inflammatory bowel diseases.
    Yu TB; Dodd S; Yu LG; Subramanian S
    PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
    Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
    Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn's disease and ulcerative colitis.
    Zilberman L; Maharshak N; Arbel Y; Rogowski O; Rozenblat M; Shapira I; Berliner S; Arber N; Dotan I
    Digestion; 2006; 73(4):205-9. PubMed ID: 16837810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory and Lipid-Associated Markers of Cardiovascular Diseases in Children with First Exacerbation of Inflammatory Bowel Disease.
    Pac-Kożuchowska E; Krawiec P; Mroczkowska-Juchkiewicz A; Pawłowska-Kamieniak A; Kominek K
    Med Sci Monit; 2016 May; 22():1534-9. PubMed ID: 27150426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.
    Caliskan Z; Gokturk HS; Caliskan M; Gullu H; Ciftci O; Ozgur GT; Guven A; Selcuk H
    Microvasc Res; 2015 Jan; 97():25-30. PubMed ID: 25128749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
    Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
    Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.
    Kovacs M; Papp M; Lakatos PL; Jacobsen S; Nemes E; Polgar M; Solyom E; Bodi P; Horvath A; Molnar K; Szabo D; Cseh A; Muller KE; Dezsofi A; Arato A; Veres G
    J Crohns Colitis; 2013 Mar; 7(2):134-41. PubMed ID: 22504031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study.
    Zissimopoulos A; Vradelis S; Konialis M; Chadolias D; Bampali A; Constantinidis T; Efremidou E; Kouklakis G
    Scand J Gastroenterol; 2014 Aug; 49(8):942-9. PubMed ID: 24897131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
    Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
    Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced formation of advanced oxidation protein products in IBD.
    Krzystek-Korpacka M; Neubauer K; Berdowska I; Boehm D; Zielinski B; Petryszyn P; Terlecki G; Paradowski L; Gamian A
    Inflamm Bowel Dis; 2008 Jun; 14(6):794-802. PubMed ID: 18213700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell distribution width for assessment of activity of inflammatory bowel disease.
    Cakal B; Akoz AG; Ustundag Y; Yalinkilic M; Ulker A; Ankarali H
    Dig Dis Sci; 2009 Apr; 54(4):842-7. PubMed ID: 18716874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease.
    Shentova R; Baycheva M; Kofinova D; Hadjiiski P; Yaneva P
    Folia Med (Plovdiv); 2020 Jun; 62(2):271-275. PubMed ID: 32666743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.